Medical Procedure News

RSS

SpinalMotion announces completion of enrollment in Kineflex lumbar artificial disc study

SpinalMotion, Inc., developer of the investigational Kineflex® lumbar and Kineflex®|C cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach. The data from the study will be used to support regulatory submissions for international commercialization.

5 Oct 2010

Supplemental brief dynamic therapy does not benefit patients with obsessive-compulsive disorder: Study

This study demonstrates that supplemental brief dynamic therapy in the treatment of patients with obsessive compulsive-disorder with concurrent major depressive disorder (who are receiving effective medication) has no significant clinical effect on both obsessive and depressive symptoms.

5 Oct 2010

International conference on brain stimulation in psychiatry and neurology to be held October 7 and 8

Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.

5 Oct 2010

USPTO approves Microdroplet botulinum toxin treatment

The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.

5 Oct 2010

Covidien to showcase innovative surgical products at 96th ACS Clinical Congress

Covidien, a leading global provider of healthcare products, will preview new devices and showcase some of the Company's most innovative products at the 96th Annual Clinical Congress of the American College of Surgeons.

5 Oct 2010

Scientists use directed light to cause arrhythmia in genetically modified mice

Scientists at the University of Bonn have altered cardiac muscle cells to make them controllable with light. They were thus able to use directed light to cause conditions such as arrhythmia in genetically modified mice. The method opens up completely new possibilities for researching the development of such arrhythmias. The study will be published in the upcoming edition of "Nature Methods".

5 Oct 2010

Race, ethnicity affect diagnostic delay more than insurance status for women with breast abnormalities

Race and ethnicity appeared to affect diagnostic delay more than insurance status for women with breast abnormalities, as revealed by data presented at the Third American Association for Cancer Research Conference on The Science of Cancer Health Disparities, being held Sept. 30-Oct. 3, 2010.

5 Oct 2010

New minimally-invasive surgical technique for esophageal high-grade dysplasia and Barrett's esophagus

Constantine Frantzides M.D., Ph.D., F.A.C.S., Director of the Chicago Institute of Minimally Invasive Surgery, staff surgeon and Director of the Laparoscopic Fellowship Program at Saint Francis Hospital, has pioneered a new minimally-invasive surgical technique for the treatment of Barrett's esophagus and high-grade dysplasia.

5 Oct 2010

Octapharma USA launches wilate replacement therapy Web site for von Willebrand Disease

Octapharma USA has launched a comprehensive Web site for wilate® at www.wilateusa.com to provide von Willebrand disease healthcare professionals and patients with easily accessible information, news and updates. The U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate® (von Willebrand Factor/Factor VIII Concentrate, Human), the first replacement therapy developed specifically for von Willebrand Disease (VWD).

5 Oct 2010

Researchers develop pioneering method to identify lytic enzymes for optimum bacteria killing characteristics

With the worrying rise of antibiotic-resistant superbugs like MRSA, scientists from a wide range of disciplines are teaming up to identify alternative therapies to keep them at bay.

5 Oct 2010

Family based treatment more effective than traditional individual-based therapy for anorexia nervosa

An anorexia nervosa treatment strategy that promotes parental involvement in restoring an adolescent to healthy weight and eating habits is more effective than traditional individual-based anorexia nervosa therapy, according to new research.

5 Oct 2010

Materialise launches SurgiCase Orthopaedics for complex reconstructive bone procedures

Putting an end to the search for a tool that will allow orthopaedic surgeons craft patient-specific solutions to extraordinary cases, Materialise is announcing the launch of SurgiCase(R) Orthopaedics. It's a comprehensive service that centers on the use of CT/MRI images in virtual surgical planning, the construction of cutting and drill guides individualized to fit the patient, and physical patient models.

5 Oct 2010

Ceremed awarded NIH SBIR grant to develop soluble carrier for topical delivery of antibiotic Vancomycin

Ceremed, Inc. was awarded a Small Business Innovation Research (SBIR) grant, the company's third in a series of grants from the National Institutes of Health to develop a versatile soluble carrier with bone hemostatic properties for targeted delivery of therapeutic agents directly to surgical sites. The recently awarded grant will aid Ceremed in its effort to develop a soluble carrier to topically deliver the antibiotic Vancomycin.

5 Oct 2010

CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations

California Healthcare Institute today submitted formal comments to the U.S. Food and Drug Administration (FDA) regarding the Center for Devices and Radiological Health 510(k) Working Group Preliminary Report and Recommendations, which could transform the 510(k) regulatory process for new medical devices, greatly affecting innovation and public health in California. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

5 Oct 2010

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Oct 2010

Estech adds COBRA Revolution Bipolar Clamp to ablation product line

Estech, a leading provider of minimally invasive cardiac surgery devices, today announced the launch of its COBRA Revolution™ Bipolar Clamp for use in surgical ablation procedures. The new instrument enables deep transmural lesion formation after a single application and is the only clamp to feature reversible jaws, which uniquely allows surgeons to follow anatomic contours, for unprecedented ease of use and efficiency.

5 Oct 2010

Titan Spine to release new Endoskeleton TC system in first-quarter 2011

Titan Spine announced that it will begin full commercial release of its new Endoskeleton® TC system first quarter of 2011. The Endoskeleton® TC is an interbody fusion device for the cervical spine. The product received 510(k) clearance in July of this year and has been in limited market release since early August. The device has an acid etched titanium surface and is biomechanically designed to promote spinal fusion.

4 Oct 2010

Medical Procedure News

SpinalMotion announces completion of enrollment in Kineflex lumbar artificial disc study

Supplemental brief dynamic therapy does not benefit patients with obsessive-compulsive disorder: Study

International conference on brain stimulation in psychiatry and neurology to be held October 7 and 8

USPTO approves Microdroplet botulinum toxin treatment

Covidien to showcase innovative surgical products at 96th ACS Clinical Congress

Scientists use directed light to cause arrhythmia in genetically modified mice

Race, ethnicity affect diagnostic delay more than insurance status for women with breast abnormalities

New minimally-invasive surgical technique for esophageal high-grade dysplasia and Barrett's esophagus

Octapharma USA launches wilate replacement therapy Web site for von Willebrand Disease

Researchers develop pioneering method to identify lytic enzymes for optimum bacteria killing characteristics

Family based treatment more effective than traditional individual-based therapy for anorexia nervosa

Materialise launches SurgiCase Orthopaedics for complex reconstructive bone procedures

Ceremed awarded NIH SBIR grant to develop soluble carrier for topical delivery of antibiotic Vancomycin

CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Estech adds COBRA Revolution Bipolar Clamp to ablation product line

Titan Spine to release new Endoskeleton TC system in first-quarter 2011

X-rays increase risk of developing childhood leukemia

FDA clears Orthovita's VITOMATRIX Bone Graft Substitute for dental procedures

FDA approves NovaBone Putty MIS Delivery System for orthopedic surgery

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News